Literature DB >> 29443124

Care of persons with MS in clinical practice: Management by majority.

Ruth Ann Marrie1, Michael K Racke1.   

Abstract

Entities:  

Year:  2016        PMID： 29443124      PMCID： PMC5727704          DOI： 10.1212/CPJ.0000000000000281

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  14 in total

1.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; B A C Cree; E C Crabtree; D S Goodin; E Waubant; D Pelletier
Journal:  Neurology       Date:  2011-01-26       Impact factor: 9.910

2.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

3.  Risk tolerance to MS therapies: Survey results from the NARCOMS registry.

Authors:  Robert J Fox; Amber Salter; Joan M Alster; Neal V Dawson; Michael W Kattan; Deborah Miller; Sneha Ramesh; Tuula Tyry; Brian W Wells; Gary Cutter
Journal:  Mult Scler Relat Disord       Date:  2015-03-26       Impact factor: 4.339

Review 4.  The Patient Protection and Affordable Care Act and Chronic Neurological Illnesses: Benefits and Challenges.

Authors:  Gregory J Esper; Daniel Hartung; Orly Avitzur
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

5.  Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Authors:  Emmanuelle Le Page; David Veillard; David A Laplaud; Stéphanie Hamonic; Rasha Wardi; Christine Lebrun; Fabien Zagnoli; Sandrine Wiertlewski; Véronique Deburghgraeve; Marc Coustans; Gilles Edan
Journal:  Lancet       Date:  2015-06-28       Impact factor: 79.321

Review 6.  Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.

Authors:  Carlo Tornatore; J Theodore Phillips; Omar Khan; Aaron E Miller; Mark Hughes
Journal:  Neurol Clin Pract       Date:  2016-08

7.  Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Jeffrey Cohen; Anna Belova; Krzysztof Selmaj; Christian Wolf; Maria Pia Sormani; Janine Oberyé; Evelyn van den Tweel; Roel Mulder; Norbert Koper; Gerrit Voortman; Frederik Barkhof
Journal:  JAMA Neurol       Date:  2015-12       Impact factor: 18.302

8.  Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.

Authors:  Dennis N Bourdette; Daniel M Hartung; Ruth H Whitham
Journal:  Neurol Clin Pract       Date:  2016-04

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  The challenge of comorbidity in clinical trials for multiple sclerosis.

Authors:  Ruth Ann Marrie; Aaron Miller; Maria Pia Sormani; Alan Thompson; Emmanuelle Waubant; Maria Trojano; Paul O'Connor; Stephen Reingold; Jeffrey A Cohen
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.